...
首页> 外文期刊>Clinical infectious diseases >Prolonged infectiousness of tuberculosis patients in a directly observed therapy short-course program with standardized therapy.
【24h】

Prolonged infectiousness of tuberculosis patients in a directly observed therapy short-course program with standardized therapy.

机译:在直接观察到的标准化治疗短程治疗方案中,结核病患者的传染性延长。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: Effective tuberculosis control is compromised by a lack of clarity about the timeframe of viable Mycobacterium tuberculosis shedding after treatment initiation under programmatic conditions. This study quantifies time to conversion from smear and culture positivity to negativity in unselected tuberculosis patients receiving standardized therapy in a directly observed therapy short-course (DOTS) program. METHODS: Longitudinal cohort study following up 93 adults initiating tuberculosis therapy in Lima, Peru. Baseline culture and drug susceptibility tests (DSTs) were performed using the MBBacT, proportion, and microscopic observation drug susceptibility (MODS) methods. Smear microscopy and MODS liquid culture were performed at baseline and weekly for 4 weeks then every other week for 26 weeks. RESULTS: Median conversion time from culture positivity to culture negativity of 38.5 days was unaffected by baseline smear status. Patients with fully susceptible tuberculosis had a median time to culture conversion of 37 days; 10% remained culture positive at day 60. Delayed culture conversion was associated with multidrug resistance, regardless of DST method used; non-multidrug resistance as defined by the proportion method and MODS (but not MBBacT) was also associated with delay. Persistent day 60 smear positivity yielded positive and negative predictive values of 67% and 92%, respectively, for detecting multidrug resistance. CONCLUSIONS: Smear and culture conversion in treated tuberculosis patients takes longer than is conventionally believed, even with fully susceptible disease, and must be accounted for in tuberculosis treatment and prevention programs. Persistent day 60 smear positivity is a poor predictor of multidrug resistance. The industrialized-world convention of universal baseline DST for tuberculosis patients should become the standard of care in multidrug resistance-affected resource-limited settings.
机译:背景:在程序化条件下开始治疗后,关于存活的结核分枝杆菌脱落的时间框架缺乏明确性,影响了有效的结核病控制。这项研究量化了在直接观察短期治疗(DOTS)计划中接受标准化治疗的未选出结核病患者中,从涂片和培养阳性转变为阴性的时间。方法:纵向队列研究追踪了秘鲁利马的93名开始接受结核病治疗的成年人。使用MBBacT,比例和显微镜观察药物敏感性(MODS)方法进行基线培养和药物敏感性试验(DST)。在基线和每周进行涂片显微镜检查和MODS液体培养4周,然后每隔一周进行26周。结果:从培养阳性到培养阴性的平均转化时间为38.5天,不受基线涂片状态的影响。完全易感肺结核患者的培养时间中位数为37天;在第60天,仍有10%的培养物为阳性。无论采用何种DST方法,延迟的培养物转化与多药耐药性相关;比例法和MODS(而非MBBacT)定义的非多药耐药性也与延迟相关。持续60天涂片阳性的阳性预测值和阴性预测值分别为67%和92%,用于检测多药耐药性。结论:即使是完全易感疾病,治疗结核病患者的涂片和培养转换所花费的时间也比传统上认为的更长,并且必须在结核病治疗和预防计划中予以考虑。持续60天涂片阳性是多药耐药性的不良预测指标。结核病患者通用基线DST的工业化世界公约应成为受多药耐药性影响的资源有限的医疗标准。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号